Company profile
Targeted Medical Pharma, Inc.
OTC: TRGM · Healthcare · Medical - Pharmaceuticals
#699 of 1,418 Healthcare companies by revenue26th-percentile growth
EA Score
——FH —DQ —GM —SS 36
v0.1 · 5/100 weight · pillars only
↑ growth stability, Piotroski F · ↓ market scale, balance-sheet leverage
Methodology →Revenue TTM
$5.3M
Rev growth YoY (TTM)
-26.0%
Net income (FY)
-$3.0M
Employees
30
as of 2026-08-31
Market cap
$302
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.3M$5.3M2015
Net income-$3.0M-$3.0M2015
Operating income-$2.0M-$2.0M2015
Total assets$2.4M$2.4M2015
Liabilities$15.3M$15.3M2015
Equity-$12.9M-$12.9M2015
Revenue trend
FY2008 – FY2015 · USD
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Targeted Medical Pharma, Inc.’s revenue?
Targeted Medical Pharma, Inc. booked $5.3M in FY2015 revenue, contracting 26% year over year — slower than 74% of Healthcare companies we track, at a -57.9% net margin.
Peers · Healthcare
WellQuest Medical & Wellness Corporation——Wildflower Brands Inc.——Biomerica, Inc.——Plus Therapeutics, Inc.30DPlus Therapeutics, Inc.38DZeo ScientifiX, Inc.43DNeighbors
Los Angeles →Key facts
CEOCameron Tymstra
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersLos Angeles, CA
ExchangeOTC: TRGM
Employees30
IPO date2012-11-02
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.